Parabilis Medicines, Inc. (PBLS)
38.53
-0.83
(-2.11%)
USD |
NASDAQ |
Aug 24, 16:00
38.53
0.00 (0.00%)
After-Hours: 20:00
Parabilis Medicines Profit Margin (Quarterly) : -35.45K% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -35.45K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Moderna, Inc. | -539.3% |
| Kailera Therapeutics, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
Profit Margin (Quarterly) Related Metrics
| Gross Profit Margin (Quarterly) | -300.7% |
| Operating Margin (Quarterly) | -34.38K% |